InsidersTradesSigma
Follow the 圣湘生物 share price and the full insider trade history of the company, a publicly traded company based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 圣湘生物 has recorded 2 insider filings. Market capitalisation: €8.8bn. The latest transaction was filed on 21 January 2022 (Purchase). Among the most active insiders: 戴立忠. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
圣湘生物 is a company focused on the healthcare and pharmaceutical sector, providing innovative solutions for diagnosis and treatment. It is listed on the Shanghai Stock Exchange under the symbol XSHG.